Seung-yong Seo
Incheon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Development and characterization of a topical ferrochelatase inhibitor nanoemulsion for choroidal neovascularization therapy.
Journal: International journal of pharmaceutics: X
Published: April 07, 2026
A derivative of PD156707 selectively inhibits NLRP3 inflammasome activation by directly binding to NLRP3.
Journal: Scientific reports
Published: November 15, 2025
Targeting YAP-TEAD Interaction with Honokiol to Inhibit Melanoma Progression and Metastasis.
Journal: Biomolecules & therapeutics
Published: November 01, 2025
Correction to: p21-Activated Kinase 4 and Ischemic Acute Kidney Injury in Mice and Humans.
Journal: Journal of the American Society of Nephrology : JASN
Published: July 11, 2025
Deep learning identifies TP-41 for methylglyoxal scavenging in Alzheimer's treatment.
Journal: Theranostics
Published: February 05, 2025
p21-Activated Kinase 4 and Ischemic Acute Kidney Injury in Mice and Humans.
Journal: Journal of the American Society of Nephrology : JASN
Published: September 20, 2024
Screening of tumor antigens and immunogenic cell death landscapes of prostate adenocarcinoma for exploration of mRNA vaccine.
Journal: Expert review of vaccines
Published: August 28, 2024
Correction: Samsuzzaman et al. A Synthetic Derivative SH 66 of Homoisoflavonoid from Liliaceae Exhibits Anti-Neuroinflammatory Activity against LPS-Induced Microglial Cells. Molecules 2024, 29, 3037.
Journal: Molecules (Basel, Switzerland)
Published: July 09, 2024
A Synthetic Derivative SH 66 of Homoisoflavonoid from Liliaceae Exhibits Anti-Neuroinflammatory Activity against LPS-Induced Microglial Cells.
Journal: Molecules (Basel, Switzerland)
Published: May 24, 2024
Last Updated: 09/26/2026